You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment-Experienced

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Hemophagocytic Lymphohistiocytosis Trial in China (Emapalumab-Lzsg 5 MG/ML [Gamifant])

Recruiting
  • Primary Hemophagocytic Lymphohistiocytosis
  • Emapalumab-Lzsg 5 MG/ML [Gamifant]
  • Shanghai, Fudan, China
  • +6 more
Feb 23, 2023

Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Phoenix, Arizona
  • +4 more
Sep 8, 2022

HIV, HIV-1 Trial in Worldwide (Etravirine)

Active, not recruiting
Has Results
  • HIV Infections
  • HIV-1
  • Los Angeles, California
  • +30 more
Jan 17, 2023

Macular Degeneration Trial (Zimura, Avastin, Lucentis)

Completed
  • Macular Degeneration
  • (no location specified)
Oct 4, 2022

Helicobacter Pylori Trial in Shibin Al Kawm (Naïve patients - ACO therapy, Naïve patients - LNDL therapy, Naïve patients - MNDL

Recruiting
  • Helicobacter Pylori
  • Naïve patients - ACO therapy
  • +4 more
  • Shibīn Al Kawm, Menoufia, Egypt
    National Liver institute - Menoufia University
Dec 21, 2021

HIV-1-infection Trial in Palm Springs (B/F/TAF)

Recruiting
  • HIV-1-infection
  • Palm Springs, California
    DAP Health
Dec 6, 2021

Primary Immunodeficiency Trial in United States (IGSC 20%)

Completed
  • Primary Immunodeficiency
  • IGSC 20%
  • Birmingham, Alabama
  • +11 more
Nov 2, 2022

d by Cancer Patients Receiving Primary Treatment and Cancer

Recruiting
  • Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    HIV Trial (Financial Literacy Training (FLT) Workshops, Incentivized Matched Youth Savings Accounts (YSA) with income-generating

    Not yet recruiting
    • HIV
    • Financial Literacy Training (FLT) Workshops
    • +4 more
    • (no location specified)
    Oct 26, 2022

    Placebo Effect, Pain Trial in Hanover (Observed Success, Observed Failure, Experienced Success)

    Not yet recruiting
    • Placebo Effect
    • Pain
    • Observed Success
    • +3 more
    • Hanover, New Hampshire
      Dartmouth College
    Jun 17, 2022

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 29, 2021

    HIV-1-infection Trial in Kenya (Dolutegravir)

    Completed
    • HIV-1-infection
    • Kiambu, Kenya
    • +3 more
    Jan 26, 2022

    Bullying, Weight, Body, Trauma, Psychological Trial in New Haven (CBT for Weight Bullying)

    Recruiting
    • Bullying
    • +2 more
    • CBT for Weight Bullying
    • New Haven, Connecticut
      Yale University School of Medicine
    Sep 20, 2022

    Pain, Cancer, Veins Trial in Vejle (Arm training)

    Not yet recruiting
    • Pain
    • +2 more
    • Arm training
    • Vejle, Southern Jutland, Denmark
      Vejle Hospital
    Feb 3, 2023

    HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)

    Active, not recruiting
    • HIV-1-infection
    • Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
    • Antwerp, Belgium
    • +28 more
    May 23, 2022

    Zepatier in Patients With Substance Use

    Active, not recruiting
    • Hepatitis C
    • +3 more
    • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
    • Chicago, Illinois
      University of Illinois at Chicago
    Jun 28, 2022

    Abdominal Aortic Aneurysms With Challenging Anatomy Trial in Eindhoven (Endurant Stent Graft)

    Active, not recruiting
    • Abdominal Aortic Aneurysms With Challenging Anatomy
    • Endurant Stent Graft
    • Eindhoven, Noord-Brabant, Netherlands
      Catharina Ziekenhuis
    Jul 28, 2022

    Dental Anxiety Trial in Jerusalem (sensory adapted waiting room)

    Completed
    Has Results
    • Dental Anxiety
    • sensory adapted waiting room
    • Jerusalem, Hadassah, Israel
      Hadassah Medical Organization
    Oct 7, 2021

    Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    HIV Trial (Vicriviroc 30 mg, Vicriviroc 20 mg, Placebo)

    Completed
    Has Results
    • HIV Infections
    • Vicriviroc 30 mg
    • +3 more
    • (no location specified)
    May 12, 2021

    Dolutegravir Plus Lamivudine Simplified Therapy

    Recruiting
    • HIV/AIDS
    • DTG+ 3TC
    • Guangzhou, Guangdong, China
      Guangzhou 8th People's Hospital
    Jul 19, 2021

    Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

    Active, not recruiting
    • Hepatitis C Virus (HCV)
      • Chelyabinsk, Russian Federation
      • +9 more
      Mar 1, 2022

      Atrial Fibrillation, Catheter Ablation Trial in Antwerp, Rotterdam, Novosibirsk

      Active, not recruiting
      • Atrial Fibrillation
      • Catheter Ablation
        • Antwerp, Belgium
        • +2 more
        Jan 25, 2022

        Severity of Drug Interactions Before and After Switching

        Completed
        • HIV/AIDS
        • bictegravir/emtricitabine/tenofovir alafenamide
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        Oct 5, 2020

        HIV Trial in Puerto Rico, United States (PRO 140, Placebo, Optimized Background Regimen)

        Completed
        • HIV
        • PRO 140
        • +2 more
        • Fountain Valley, California
        • +36 more
        Sep 28, 2021